Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Belachew Umeta"'
Autor:
Abera Milkesa, Gemmechu Hasen, Tesfaye Mohammed, Yesuneh Tefera Mekasha, Duresa Dedefo, Belachew Umeta, Sultan Suleman
Publikováno v:
PLoS ONE, Vol 19, Iss 11, p e0310828 (2024)
BackgroundThe incidence of hypertension in persons 25 years of age and older is estimated to be 46% in Africa, where it is still very common. This concerning rate could be explained by the pharmaceutical markets' accessibility to poor quality antihyp
Externí odkaz:
https://doaj.org/article/3bad7f096e8b49cc8cf4de1ee6942858
Autor:
Yesuneh Tefera Mekasha, Belachew Umeta Chali, Anbessa Bekele Feissa, Gemmechu Hasen Godena, Hassen Kebede Hassen, Sultan Suleman Wega
Publikováno v:
PLoS ONE, Vol 18, Iss 3 (2023)
Background Azithromycin is a therapeutically” relevant macrolide antibiotic registered on the Essential Medicines List of the World Health Organization. The fact that medicine is selected as an essential drug doesn’t mean that it is of good quali
Externí odkaz:
https://doaj.org/article/a37c3191ff9942669b2774bebda715f1
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 7, Iss 1, Pp 1-7 (2021)
Abstract Background Human immune deficiency virus (HIV) increases the susceptibility to primary infection or reinfection and the risk of tuberculosis (TB) reactivation for patients with latent TB. There was no current report on the rate of active TB
Externí odkaz:
https://doaj.org/article/33e820b0b78c41cfb28092ec1d293283
Autor:
Belachew Umeta, Temesgen Mulugeta, Girma Mamo, Sintayehu Alemu, Nimona Berhanu, Gudina Milkessa, Birhanu Mengistu, Tsegaye Melaku
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 15, Iss 1 (2022)
Background The COVID-19 pandemic has brought new situations that require the effective delivery of health information across the world and it’s important to offer clear, consistent, and credible information on the pandemic to mitigate and control t
Externí odkaz:
https://doaj.org/article/4ab061b444c142208b3a07b5c3a81b65
Autor:
Firew Asres, Belachew Umeta
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 15, Iss 1 (2022)
Background The myths and conspiracy theories on the COVID-19 vaccine cause people to be hesitant and maleficent towards the vaccine. Objectives To assess COVID-19 vaccine-related awareness, attitude and acceptance and to assess reasons for refusing t
Externí odkaz:
https://doaj.org/article/c35cb3cb8df74bd390fba1ec98e65396
Autor:
Nimona Berhanu, Zewdie Birhanu, Tidenek Mulugeta, Tadesse Gudeta, Belachew Umeta, Gizachew Tilahun
Publikováno v:
PLoS ONE, Vol 17, Iss 10 (2022)
Background Satisfaction with pharmacy services has many implications, including the degree of interaction with health care providers, the type and quality of service provided, and the extent to which needs and desires are met. This study aimed to ide
Externí odkaz:
https://doaj.org/article/7c718b7f744747638c687806a3fc86ce
Publikováno v:
Advances in Pharmacological and Pharmaceutical Sciences, Vol 2021 (2021)
Background. The availability of poor-quality drugs on the drug market might favor the ineffectiveness of the drug and/antimicrobial resistance. Aim. To evaluate the quality of similar batches of ethambutol hydrochloride tablets available in different
Externí odkaz:
https://doaj.org/article/a8623151359549d48322f2294c20c79c
Autor:
Mekasha, Yesuneh Tefera1 (AUTHOR) yetefera29@gmail.com, Chali, Belachew Umeta2 (AUTHOR), Feissa, Anbessa Bekele2 (AUTHOR), Godena, Gemmechu Hasen2 (AUTHOR), Hassen, Hassen Kebede3 (AUTHOR), Wega, Sultan Suleman2 (AUTHOR)
Publikováno v:
PLoS ONE. 3/2/2023, Vol. 17 Issue 3, p1-23. 23p.
Publikováno v:
Infection and Drug Resistance. 15:6085-6092
The use of poor quality drugs will have multiple consequences with an extended hazard of growing drug-resistant strains.The review aimed to provide the quality status of antimalarial drugs in East Africa.PubMed, Scopus, Web of Science, and Google Sch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aecaa7fc8afc911b9dc1901c6fc09b69
https://doi.org/10.2147/idr.s373059
https://doi.org/10.2147/idr.s373059
Autor:
Tsegaye Melaku, Belachew Umeta Chali, Girma Mamo, Gudina Milkessa, Nimona Berhanu, Birhanu Mengistu, Sintayehu Alemu, Temesgen Mulugeta
Publikováno v:
Infection and Drug Resistance
Belachew Umeta Chali,1 Tsegaye Melaku,2 Nimona Berhanu,3 Birhanu Mengistu,4 Gudina Milkessa,5 Girma Mamo,2 Sintayehu Alemu,1 Temesgen Mulugeta2 1Department of Pharmaceutical Sciences, School of Pharmacy, Institute of Health, Jimma University, Jimma,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72faa5ff1860a7cd12091b57094bd1f4
https://doi.org/10.2147/idr.s331434
https://doi.org/10.2147/idr.s331434